SCHEMBL482543

SCHEMBL482543

COC(=O)C(C)[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14744178 0.78
SCHEMBL36713 0.78
SCHEMBL2322217 0.78
SCHEMBL10188439 0.78
SCHEMBL784551 0.76 SMN1; SMN2 (0.52)
SCHEMBL5411161 0.76 SMN1; SMN2 (0.50)
SCHEMBL846523 0.76 SMN1; SMN2 (0.52)
SCHEMBL275280 0.76 SMN1; SMN2 (0.52)
SCHEMBL13946795 0.76 SMN1; SMN2 (0.52)
SCHEMBL66536 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 738 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4252297-A1 NON-AQUEOUS REDOX FLOW BATTERIES ENI S.p.A. (IT) 2023-10-04 EP claimed
CN-116472636-A Nonaqueous redox flow battery 埃尼股份公司 2023-07-21 CN claimed
WO-2022112932-A1 NON-AQUEOUS REDOX FLOW BATTERIES ENI S.P.A. (IT) 2022-06-02 WO claimed
EP-3424926-A1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINS, THEIR PRODUCTION AND UTILISATION AS MEDICINE Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2019-01-09 EP claimed
EP-2308878-A2 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and use as medicaments Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-04-13 EP claimed
EP-2070539-A1 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-06-17 EP claimed
EP-2060573-A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-05-20 EP claimed
EP-2058311-A2 8-[3-amino-piperidin-1-yl]-xanthins, their production and utilisation as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-05-13 EP claimed
US-7521396-B2 Substituted (thioxo)carbonylaminophenyluracils BAYER CROPSCIENCE AG (DE) 2009-04-21 US claimed
JP-4233524-B2 2009-03-04 JP claimed
WO-1991005001-A1 YTTRIUM AND RARE EARTH COMPOUNDS CATALYZED LACTONE POLYMERIZATION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-04-18 WO claimed
EP-0415212-A1 Aryloxynaphthalene derivatives BAYER AG (DE) 1991-03-06 EP claimed
US-4981864-A ANTICOAGULANTS BOEHRINGER MANNEHIM GMBH (DE) 1991-01-01 US claimed
EP-0245902-A2 Benzothiazinone derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-11-19 EP claimed
EP-0245901-A2 Thiazinone derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1987-11-19 EP claimed
EP-0094641-B1 DIPHENYL SULFONE COMPOUNDS, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-09-10 EP claimed
US-4565569-A HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-01-21 US claimed
US-4545812-A HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-10-08 US claimed
EP-0094641-A2 Diphenyl sulfone compounds, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-11-23 EP claimed
US-4140684-A FOR POLYESTERS, POLYAMIDES, AND CELLULOSE ACETATES FIDELITY UNION TRUST COMPANY, EXECUTIVE TRUSTEE UNDER THE SANDOZ TRUST (US) 1979-02-20 US claimed